George Dorfman

Company: Mission Bio

Job title: Director, Cell Gene Therapy Business & Market Development

Seminars:

Addressing Comparability and Regulatory QC Assays Through Multi-Modal Single-Cell Analysis 1:30 pm

CAR-T therapies (both autologous and allogeneic) are currently experiencing headwinds, and a major issue is sufficient analytical characterization to capture CQAs in a uniform and consistently reliable, rapid manner Regulatory and QC endpoints are coming under increased scrutiny, while patients are endlessly waiting for these therapies to be democratized and accessible This presentation will address…Read more

day: Day 1 - Track B - Afternoon